Application 021039

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AGENERASEAMPRENAVIRSOLUTION;ORAL15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021039-001AGENERASEAMPRENAVIR15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / ORALRLD1999-04-15

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021039-001AGENERASE15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / ORALRLD1999-04-153a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021039-001AGENERASE15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / ORALRLD1999-04-15f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N021039-001AGENERASE15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / ORALRLD1999-04-15e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N021039-001AGENERASE15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / ORALRLD1999-04-15cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N021039-001AGENERASE15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / ORALRLD1999-04-15a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
26567SUPPL2005-11-18
35960SUPPL2005-11-08
21370SUPPL2004-05-26
21369ORIG2004-05-26
14231SUPPL2004-04-05
4137SUPPL2004-03-02
35959SUPPL2002-10-02
26566SUPPL2002-10-02
14230SUPPL2002-10-02
4136SUPPL2002-10-02
26565SUPPL2002-08-02
14229SUPPL2002-08-02
26564SUPPL2002-02-05
4135SUPPL2002-02-05
26563SUPPL2001-05-11
14228SUPPL2001-05-11
14227ORIG1999-04-15
4134ORIG1999-04-15